Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.9K
Overview
43.9K
Vaccines01:21

Vaccines

86
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
86
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.5K
Autoimmune Disorders01:29

Autoimmune Disorders

2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

261
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
261
Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lupus nephritis.

Nature reviews. Disease primers·2025
Same author

Anti-CD20 therapy in lupus nephritis: A revisit.

Rheumatology and immunology research·2025
Same author

Immunotargets and Therapy for Systemic Lupus Erythematosus.

ImmunoTargets and therapy·2025
Same author

The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS.

Therapeutic advances in musculoskeletal disease·2025
Same author

Targeting the ubiquitin-proteasome pathway in systemic lupus erythematosus.

Expert review of clinical immunology·2025
Same author

Glucocorticoid in systemic lupus erythematosus: the art beyond science.

Expert review of clinical immunology·2025

Related Experiment Video

Updated: Apr 27, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K

Vaccination in systemic lupus erythematosus.

Tsz Ching Mok1, Chi Chiu Mok2

  • 1Department of Medicine, Ruttonjee Hospital, Hong Kong, SAR China.

Human Vaccines & Immunotherapeutics
|April 25, 2026
PubMed
Summary

Vaccination is crucial for systemic lupus erythematosus (SLE) patients to prevent infections. While most tolerate vaccines, individualized plans are essential, especially for those on immunosuppression, considering risks and benefits.

Keywords:
Vaccineimmunosuppressioninfectionlupusmorbidity

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

211

Related Experiment Videos

Last Updated: Apr 27, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

211

Area of Science:

  • Immunology
  • Rheumatology
  • Infectious Disease

Background:

  • Infection is a primary cause of mortality in systemic lupus erythematosus (SLE) patients.
  • Vaccination is a key strategy to mitigate infection risk in this vulnerable population.

Purpose of the Study:

  • To review the current evidence on vaccination strategies for patients with SLE.
  • To evaluate vaccine immunogenicity, safety, and optimal timing in SLE management.

Main Methods:

  • Literature review of studies on vaccine response in SLE patients.
  • Analysis of data regarding immunogenicity of various vaccines (e.g., SARS-CoV2, influenza, pneumococcal).
  • Assessment of SLE flare risk post-vaccination and considerations for immunosuppressed individuals.

Main Results:

  • Most SLE patients achieve adequate immune responses to SARS-CoV2 vaccines, but lower immunogenicity is seen with influenza and pneumococcal vaccines.
  • Current evidence does not link common vaccines to an increased risk of SLE flares.
  • Vaccine responses are attenuated in patients receiving intense immunosuppression or B-cell depleting therapies.

Conclusions:

  • Individualized vaccination decisions are necessary for SLE patients, balancing risks and benefits.
  • Vaccination is recommended during periods of low disease activity or remission.
  • Live vaccines are less preferred than inactivated or recombinant vaccines for immunosuppressed SLE patients; adjunctive measures may be considered.